TuHURA Biosciences Inc. Common Stock (HURA)
Stock · NASDAQ · Health Care
$2.11as of 8/28/2026
Price chart
Open in TradingViewActive signals
Resistance level
$2.24
Industry
Biotechnology: Pharmaceutical Preparations
About HURA
TuHURA Biosciences, Inc., a clinical stage immuno-oncology company, that develops novel technologies for the treatment of cancer immunotherapies. The company's lead product candidate includes IFx2.0, an innate immune agonist designed to overcome primary resistance to checkpoint inhibitors. It is also preparing to initiate a single randomized placebo-controlled which is in Phase 3 registration trial of IFx-2.0 adminis…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 22
- Website
- tuhurabio.com/
Fundamentals
- 1-day range
- $2.04$2.15
- Market cap
- $136.28M
- P/E (trailing)
- —
- P/E (forward)
- -3.49
- EPS (trailing)
- $-0.61
- Dividend yield
- —
- Beta
- -0.18
- Avg. volume
- 443.0K
52-week range
$0.41$3.43
Next earnings: November 13, 2026 · EPS estimate $-0.13confirmed
Forecasts
5 analyst ratings
Buy 90%
Hold 10%
Sell 0%
1-year price forecast
High
$10
+373.9%
Median
$8
+279.1%
Low
$6.2
+193.8%
TuHURA Biosciences Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- HURATuHURA Biosciences Inc. Common Stock$2.11▼ 1.17%Market cap $136.28MP/E —$0.41$3.43
- GNLXGenelux Corporation Common Stock$2.66▼ 7.64%Market cap $133.62MP/E —$2.29$8.54
- ADCTADC Therapeutics SA Common Shares$1.15▲ 2.68%Market cap $133.55MP/E —$0.7796$4.98
- MISTMilestone Pharmaceuticals Inc. Common Shares$1.17▼ 2.10%Market cap $139.44MP/E —$1$3.06
- KZIAKazia Therapeutics Limited American Depositary Shares$13.59▼ 19.59%Market cap $141.81MP/E —$4.86$17.4
- VTVTvTv Therapeutics Inc. Class A Common Stock$32.17▼ 1.92%Market cap $127.58MP/E 55.59$15.79$44
- PMNProMIS Neurosciences Inc. Common Shares (ON)$13.79▼ 1.43%Market cap $126.80MP/E —$6.27$27.4
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| HURA TuHURA Biosciences Inc. Common Stock | $136.28M | — | $2.11 | ▼ 1.17% | $0.41$3.43 |
| GNLX Genelux Corporation Common Stock | $133.62M | — | $2.66 | ▼ 7.64% | $2.29$8.54 |
| ADCT ADC Therapeutics SA Common Shares | $133.55M | — | $1.15 | ▲ 2.68% | $0.7796$4.98 |
| MIST Milestone Pharmaceuticals Inc. Common Shares | $139.44M | — | $1.17 | ▼ 2.10% | $1$3.06 |
| KZIA Kazia Therapeutics Limited American Depositary Shares | $141.81M | — | $13.59 | ▼ 19.59% | $4.86$17.4 |
| VTVT vTv Therapeutics Inc. Class A Common Stock | $127.58M | 55.59 | $32.17 | ▼ 1.92% | $15.79$44 |
| PMN ProMIS Neurosciences Inc. Common Shares (ON) | $126.80M | — | $13.79 | ▼ 1.43% | $6.27$27.4 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Citizens Reiterates Market Outperform on TuHURA Biosciences, Maintains $9 Price Targetbenzinga · 8/18/2026
- TuHURA Biosciences, Inc. (HURA) Shareholder/Analyst Call Prepared Remarks TranscriptSeekingAlpha · 8/18/2026
- Citizens Reiterates Market Outperform on TuHURA Biosciences, Maintains $9 Price TargetBenzinga · 8/18/2026
- TuHURA Biosciences Highlights Phase III IFx Push, AML Trial Plans at CanaccordYahoo · 8/14/2026
- TuHURA Biosciences Reports Second Quarter 2026 Financial Results and Provides a Corporate UpdateYahoo · 8/14/2026
- TuHURA Biosciences Q2 EPS $(0.14) Beats $(0.15) EstimateBenzinga · 8/14/2026
Insider Activity
Insider Actions →Acquired
0
Disposed
150.0K
- James A. Bianco · May 28, 2026 · Gift150.0K
Institutional Ownership
March 31, 2026
- Total shares held
- 8.89M
- Total value held
- $15.75M
- Institutional holders
- 84
Top holders this quarter
- Unknown2.45M
- Unknown2.07M
- Unknown986.9K
- Unknown607.2K
- Unknown512.9K
- Unknown298.2K
- Unknown211.6K
- Unknown158.0K
- Unknown140.2K
- Unknown104.4K
See the full, filterable feed with live charts on the MarketWall dashboard.